Category: <span>Dr. David Sugarbaker</span>

Sugarbaker Touts New Clinical Study for Mesothelioma Patients

The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute has opened a groundbreaking clinical trial combining cytoreductive surgery with a hyperthermic, intraoperative chemotherapy lavage. Dr. David Sugarbaker, chief of thoracic surgery at Baylor and one of the world’s foremost authorities on pleural mesothelioma, believes the study could lead to a major advancement…

The post Sugarbaker Touts New Clinical Study for Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Phase II Trial for New Mesothelioma Treatment Opens to Patients

A Phase II clinical trial testing a new treatment for mesothelioma is now open to patients at Baylor College of Medicine Treatment Center.

New Mesothelioma Immunotherapy Clinical Trial at Baylor University

A new clinical trial at Baylor University’s Mesothelioma Treatment Center is looking at the effectiveness of using immunotherapy before surgery.